# PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)

> **NCT03543800** · NA · UNKNOWN · sponsor: **Antnor** · enrollment: 100 (estimated)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DEVICE:** Cytorich PRP kit
- **DEVICE:** PRP kit

## Key facts

- **NCT ID:** NCT03543800
- **Lead sponsor:** Antnor
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02-04
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03543800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03543800, "PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT03543800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*